• 1. Exchanged ligands on the surface of a giant cluster: [(MoO3)176(H2O)63(CH3OH)17Hn](32 – n)–
  Chem. Commun., 1998, 1501-1502
• 2. Emerging 2D hybrid nanomaterials: towards enhanced sensitive and selective conductometric gas sensors at room temperature
  Hanie Hashtroudi,Ian D. R. Mackinnon J. Mater. Chem. C, 2020,8, 13108-13126
• 3. Evolution of calcium phosphate precipitation in hanging drop vapor diffusion by in situRaman microspectroscopy
  Gloria Belén Ramírez-Rodríguez,José Manuel Delgado-López,Jaime Gómez-Morales CrystEngComm, 2013,15, 2206-2212
• 4. Estimates of hydride ion stability in condensed systems: energy of formation and solvation in aqueous and polar-organic solvents
  Craig A. Kelly,David R. Rosseinsky Phys. Chem. Chem. Phys., 2001,3, 2086-2090
• 5. Exceptional activity of sub-nm Pt clusters on CdS for photocatalytic hydrogen production: a combined experimental and first-principles study?
  Qiyuan Wu,Shangmin Xiong,Peichuan Shen,Shen Zhao,Alexander Orlov Catal. Sci. Technol., 2015,5, 2059-2064

• Solvents and Organic Chemicals Organic Compounds Organic nitrogen compounds Organonitrogen compounds 1,2-aminoalcohols

DL-erythro-Dihydrosphingosine (CAS No. 3102-56-5): A Comprehensive Overview

DL-erythro-Dihydrosphingosine (CAS No. 3102-56-5) is a biologically significant sphingolipid derivative that has garnered attention in biochemical and pharmaceutical research. This compound, also known as dihydrosphingosine or sphinganine, serves as a key intermediate in the biosynthesis of more complex sphingolipids, which are essential components of cell membranes and play critical roles in cellular signaling. The DL-erythro configuration indicates its stereochemistry, distinguishing it from other dihydrosphingosine isomers.

The growing interest in DL-erythro-Dihydrosphingosine is driven by its potential applications in skincare, neurodegenerative disease research, and metabolic studies. Recent advancements in lipidomics and personalized medicine have further highlighted its importance. Researchers are particularly intrigued by its role in modulating ceramide metabolism, a hotspot topic in dermatology and aging research. As consumers increasingly seek science-backed skincare solutions, compounds like DL-erythro-Dihydrosphingosine are gaining traction in cosmetic formulations aimed at improving skin barrier function.

From a chemical perspective, DL-erythro-Dihydrosphingosine (CAS No. 3102-56-5) is an 18-carbon amino alcohol with two hydroxyl groups and an amino group. Its amphiphilic nature allows it to integrate into lipid bilayers, making it valuable for membrane studies. The compound's molecular formula is C₁₈H₃₉NO₂, and it typically appears as a white to off-white powder. Its solubility profile—soluble in organic solvents like methanol and chloroform but poorly soluble in water—makes it suitable for various laboratory applications.

In the pharmaceutical industry, DL-erythro-Dihydrosphingosine is being explored for its potential in drug delivery systems. Its ability to interact with cell membranes makes it a candidate for enhancing the bioavailability of hydrophobic drugs. Additionally, its role in sphingolipid signaling pathways has sparked interest in developing therapies for conditions like multiple sclerosis and Alzheimer's disease, aligning with the current focus on neurodegenerative disorders in medical research.

The cosmetic industry has embraced DL-erythro-Dihydrosphingosine for its skin-repairing properties. As consumers demand "clean beauty" products with clinically proven ingredients, this compound is increasingly featured in serums and creams targeting moisture retention and anti-aging. Its natural occurrence in the skin's lipid barrier makes it particularly appealing for sensitive skin formulations, a trending niche in the personal care market.

From a commercial standpoint, the global market for sphingolipid derivatives like DL-erythro-Dihydrosphingosine is expanding rapidly. Pharmaceutical and cosmetic manufacturers are seeking high-purity sources of this compound, creating opportunities for specialized suppliers. Analytical techniques such as mass spectrometry and HPLC are crucial for quality control, reflecting the industry's emphasis on product standardization—a key concern for buyers searching for reliable CAS 3102-56-5 suppliers.

Recent scientific publications have shed light on novel applications of DL-erythro-Dihydrosphingosine in metabolic disease research. Its involvement in insulin signaling pathways has positioned it as a potential biomarker for diabetes management, coinciding with the global health community's intensified focus on metabolic disorders. This connection makes the compound particularly relevant to researchers investigating the lipid-metabolism interface, a hot topic in current biomedical literature.

For laboratory use, proper handling of DL-erythro-Dihydrosphingosine requires attention to storage conditions. The compound should be kept at -20°C under inert atmosphere to prevent oxidation—a common query among first-time users searching for 3102-56-5 storage guidelines. Its stability profile makes it suitable for long-term research projects, though precautions against moisture are recommended to maintain purity.

The synthesis of DL-erythro-Dihydrosphingosine has seen methodological improvements in recent years. Modern catalytic approaches have increased yields while reducing environmental impact, aligning with the pharmaceutical industry's push toward green chemistry. These advancements address frequent search queries about sustainable sphingolipid production, reflecting broader trends in environmentally conscious research and development.

As research continues to uncover the multifaceted roles of DL-erythro-Dihydrosphingosine, its importance in both basic science and applied research becomes increasingly apparent. From its fundamental contributions to our understanding of cell membrane dynamics to its emerging applications in medicine and cosmetics, this compound represents a fascinating intersection of chemistry, biology, and material science. The ongoing elucidation of its biological functions ensures that CAS 3102-56-5 will remain a subject of scientific inquiry for years to come.

• 2304-75-8(1,3-Octadecanediol,2-amino-, (2R,3R)-rel-)
• 24006-62-0(Sphinganine-C20)
• 50731-05-0(1,3-Dodecanediol, 2-amino-)
• 73938-69-9(DL-threo-Dihydrosphingosine)
• 13552-09-5(2-Aminooctadecane-1,3-diol)
• 263352-56-3(1,3-Octadecane-4,5-t2-diol,2-amino-, (2S,3R)- (9CI))
• 32164-02-6(Sphinganine-C17)
• 15639-50-6(L-threo-Dihydrosphingosine)
• 764-22-7(D-erythro-C18-Dihydro-D-sphingosine)
• 50731-08-3(1,3-Hexadecanediol, 2-amino-)